What single change could most accelerate progress across the field? We asked leading researchers, innovators and policy ...

We got a sneak peek inside Found Energy’s lab, just as it gears up to supply heat and hydrogen to its first customer.

But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

When athletes devote large amounts of energy to running or cycling, they unconsciously cut back on energy output elsewhere.

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

The research, published today in Current Biology, showed that ultramarathoners can burn an astounding 11,000 calories per day ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...